Effects of Vagus Nerve Pulmonary Branch Block on Postoperative Cough After VATS Lung Resection

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

Postoperative cough after pulmonary resection is a common issue seen after thoracic surgeries, hindering patients' recovery and affecting their postoperative quality of life. While vagus nerve pulmonary branch block has been known to reduce intraoperative coughing, its impact on postoperative cough post lung resection is uncertain. This study aims to assess the effects of vagus nerve pulmonary branch block on postoperative cough after VATS lung resection. A randomized controlled trial involving 104 thoracoscopic lung resection patients will assign them randomly to a vagus nerve pulmonary branch block group or a control group. The primary outcome measure is the postoperative cough incidence 3 weeks after lung resection. The secondary outcomes include assessing hoarseness in PACU, peak expiratory flow (PEF) on the first post-op day, NRS scores for cough, and LCQ-MC scores at 3 weeks post-surgery, as well as cough occurrence, NRS scores, and LCQ-MC scores at 8 weeks post-procedure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 70 years old.

BMI between 18 and 30 kilograms per square meter (kg/m²).

ASA Physical Status Classification of I, II, or III.

Preoperative pulmonary imaging demonstrating peripheral lesions, with clinical staging T≤2, N≤1, M0.

Disqualifiers

Patients with a history of chemotherapy or previous pulmonary surgery.

Presence of chronic cough due to respiratory infectious diseases, pharyngitis, rhinitis, COPD, asthma, post-nasal drip syndrome, etc.

Individuals exhibiting ECG abnormalities such as atrial fibrillation, bundle branch block, frequent ventricular premature beats, pre-excitation syndrome, etc.

Currently using ACE inhibitor medications.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vagus Nerve Pulmonary Branch Block

    Procedure/Surgery

    Following thoracotomy, the thoracic surgeon, under direct thoracoscopic guidance, used forceps to elevate the apex of the lung, thus exposing the main trunk of the pulmonary branches of the vagus nerve. The injection needle was then advanced from a lateral-to-medial direction, and 2.5 ml of 0.375% ropivacaine was administered in close proximity to the targeted vagal branch.

  • Vagus Nerve Pulmonary Branch Injection

    Procedure/Surgery

    Following thoracotomy, the thoracic surgeon, under direct thoracoscopic guidance, used forceps to elevate the apex of the lung, thus exposing the main trunk of the pulmonary branches of the vagus nerve. The injection needle was then advanced from a lateral-to-medial direction, and 2.5 ml of normal saline was administered in close proximity to the targeted vagal branch.

Treatment groups

104 Participants
are divided into 2 treatment groups
Group A: Vagus nerve pulmonary branch block group (V group)Experimental treatment 1 intervention
Group B: Control group (C group)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of postoperative cough following lung resection at 3 weeks post-operation

The incidence of post-lung resection cough was assessed at 3 weeks postoperatively.

Time frame
at 3 weeks post-operation

Secondary outcomes

1

Condition of hoarseness in PACU

Assessment of hoarseness in PACU following surgery

Time frame
during in PACU, an average of 1 hour
2

Peak expiratory flow rate on postoperative day 1

Measurement of peak expiratory flow on postoperative day 1

Time frame
on postoperative day 1
3

Numerical Rating Scale for cough intensity at 3 weeks post-operation

The scale ranges from 0 to 10, with 0 indicating no cough and 10 representing the worst imaginable cough.Higher scores on the Numerical Rating Scale for cough intensity indicate a more severe cough condition.

Time frame
at 3 weeks post-operation
4

Leicester Cough Questionnaire for Measuring Chronic Cough at 3 weeks post-operation

The LCQ-MC score ranges from a minimum of 0 to a maximum of 21, with three dimensions: physical, psychological, and social. Each dimension is scored from 1 to 7, and the total score is the sum of the three dimensions.Higher scores on the LCQ-MC indicate better health-related quality of life. A score of 0 represents the worst possible quality of life, while a score of 21 represents the best possible quality of life in relation to cough.

Time frame
at 3 weeks post-operation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.